Liver Health, Metabolism, and Testosterone in Midlife Men

Many men over 45 find themselves searching for explanations when routine blood tests show borderline low testosterone alongside elevated liver enzymes or rising blood sugar. You may have noticed declining energy, stubborn abdominal fat, slower recovery from workouts, and a general loss of physical drive. When you search online for answers, you often find two disconnected extremes: aggressive marketing for hormone clinics that treat testosterone as an isolated vitality number, or vague medical warnings about fatty liver and metabolic slowdown.

The reality is that your liver, metabolic health, and hormone levels do not operate in silos. They function as a single connected biological system. This guide provides a definitive, evidence-based breakdown of how liver health, insulin sensitivity, and testosterone interact in men after 45, and what you should do before considering hormone therapy.

Clinical Evidence on the Liver, Metabolism, and Hormone Connection

Clinical research shows a strong, consistent relationship between reduced testosterone levels, visceral adiposity, insulin resistance, and hepatic steatosis. Large meta-analyses confirm that men with metabolic dysfunction-associated steatotic liver disease, formerly known as non-alcoholic fatty liver disease, frequently present with significantly lower total testosterone compared to men with healthy livers. Research also shows that circulating levels of sex hormone-binding globulin, a critical transport protein produced by the liver, are substantially lower in men with excess liver fat and metabolic syndrome.

However, clinical research does not show that low testosterone independently causes fatty liver disease. Major medical organizations, including the American Association for the Study of Liver Diseases and the Endocrine Society, emphasize that this relationship is bidirectional and heavily confounded by shared underlying factors. Obesity, central fat accumulation, chronic inflammation, and insulin resistance suppress testicular hormone production while simultaneously driving fat accumulation inside liver cells.

The diagnostic consensus among leading endocrine and hepatology societies establishes a clear clinical principle. Biochemical hypogonadism must be diagnosed using accurate assays, requiring at least two separate morning fasting blood tests combined with consistent, compatible physical symptoms. In midlife men, low total testosterone often represents functional suppression caused by reversible metabolic and liver-related drivers, rather than permanent damage to the testes or pituitary gland.

When evaluating health markers after 45, clinicians prioritize identifying and resolving these metabolic and hepatic drivers before considering medical hormone replacement. Addressing insulin resistance, improving liver function, and reducing visceral fat often normalizes hormone signaling naturally. For broader educational resources on midlife hormones, visit our guide on hormone optimization and male vitality.

Biological Mechanisms and Midlife Changes After 45

The human body undergoes specific physiological shifts in midlife that alter how the liver processes nutrients and how the endocrine system produces hormones. The primary control system for male hormone production is the hypothalamic-pituitary-gonadal axis, often called the HPG axis. The hypothalamus releases gonadotropin-releasing hormone, which signals the pituitary gland to secrete luteinizing hormone and follicle-stimulating hormone. Luteinizing hormone travels through the bloodstream to stimulate the Leydig cells in the testes, which synthesize testosterone.

After age 45, several subtle changes occur across this axis:

Leydig Cell Efficiency and Central Signaling

The responsiveness of testicular Leydig cells gradually declines over the decades. In healthy aging men without chronic disease, total testosterone drops at a modest rate of roughly 1 percent per year after age 30. This gradual shift is a normal physiological process, not an acute disease state. However, when metabolic stress or liver fat accumulates, central signaling from the hypothalamus and pituitary becomes blunted, accelerating this decline.

Adipose Tissue and Aromatase Activity

As men age, visceral fat accumulation often increases around internal organs and within the abdominal cavity. Visceral fat is not an inert storage tissue, but an active endocrine organ that produces inflammatory cytokines. Adipose tissue contains high concentrations of the aromatase enzyme, which converts circulating androgens into estrogens. Increased aromatase activity shifts the systemic balance of sex steroids, sending negative feedback signals to the pituitary gland that suppress further luteinizing hormone release.

Insulin Resistance and Hepatic Fat Accumulation

Insulin resistance develops when muscle, fat, and liver cells stop responding efficiently to insulin signals. To compensate, the pancreas secretes higher amounts of insulin to clear glucose from the bloodstream. High circulating insulin stimulates de novo lipogenesis in the liver, meaning the liver converts excess circulating carbohydrates and fatty acids into triglycerides. When liver triglyceride accumulation exceeds export capacity, hepatic steatosis develops, triggering low-grade systemic inflammation that further inhibits pituitary gonadotropin secretion.

Sex Hormone-Binding Globulin and Hormone Transport Dynamics

Understanding hormone health requires looking beyond total testosterone numbers on a laboratory report. Testosterone travels through the bloodstream in three distinct forms: free testosterone, albumin-bound testosterone, and testosterone tightly bound to sex hormone-binding globulin. Only free and albumin-bound testosterone, collectively referred to as bioavailable testosterone, can easily cross cell membranes to exert biological actions in muscle, bone, brain, and metabolic tissues.

Sex hormone-binding globulin is a glycoprotein produced directly by hepatocytes in the liver. The rate at which your liver synthesizes this protein dictates the ratio between your bound and unbound hormones. In midlife men, liver health and metabolic status create two contrasting laboratory patterns that frequently mislead both patients and inexperienced practitioners.

The Low SHBG Pattern in Metabolic Syndrome

The most common pattern seen in men with central obesity, prediabetes, and early fatty liver disease is suppressed SHBG synthesis. High circulating insulin and inflammatory signals downregulate the liver's production of SHBG. Because there is less binding protein in the blood, total testosterone measurements appear significantly depressed.

However, because a smaller percentage of the hormone is locked to SHBG, calculated free testosterone may remain within or near the normal reference range. In this clinical scenario, diagnosing a man with severe organic hypogonadism based solely on a low total testosterone number is an error. The low reading is primarily a reflection of metabolic liver stress and suppressed protein synthesis.

The High SHBG Pattern in Advanced Liver Disease

The opposite pattern occurs in advanced chronic liver disease, persistent hepatitis, and cirrhosis. Structural damage and altered clearance dynamics in advanced liver disease prompt the liver to produce abnormally high concentrations of SHBG. When SHBG is high, it binds a large proportion of circulating testosterone, leaving very little unbound, biologically active hormone available for target tissues.

A man with chronic liver dysfunction might receive a routine blood test showing a total testosterone level that appears completely normal. Despite this normal total number, the patient may experience severe physical symptoms of hormone deficiency because his free and bioavailable testosterone fractions are profoundly suppressed. This demonstrates why comprehensive testing must include SHBG and calculated free testosterone whenever liver disease or metabolic dysfunction is suspected.

Metabolic Dysfunction, Visceral Adiposity, and Liver Steatosis

Metabolic dysfunction-associated steatotic liver disease has become the most prevalent chronic liver condition worldwide. Modern clinical definitions identify steatotic liver disease across distinct stages of progression:

1. Hepatic Steatosis: Simple accumulation of fat within liver cells exceeding 5 percent of total liver weight, occurring alongside at least one cardiometabolic risk factor.
2. Metabolic Dysfunction-Associated Steatohepatitis: A more severe stage where accumulated liver fat triggers cellular ballooning, active inflammation, and hepatocellular injury.
3. Hepatic Fibrosis: The progressive accumulation of stiff, fibrous scar tissue within the liver matrix in response to sustained inflammatory injury.
4. Cirrhosis: Advanced architectural disruption, extensive bridging fibrosis, and impaired hepatic vascular flow, significantly compromising liver function.

The relationship between liver fat, visceral adiposity, and testosterone creates a continuous metabolic feedback loop. When visceral fat increases, free fatty acids flow directly into the liver via the portal vein, worsening hepatic insulin resistance. As the liver becomes more resistant to insulin, it produces more triglycerides and reduces SHBG production.

Concurrently, lower testosterone signaling in skeletal muscle reduces insulin-stimulated glucose uptake and diminishes muscle protein synthesis. Skeletal muscle is the largest site of glucose disposal in the human body. As muscle mass and physical activity decline, systemic insulin resistance worsens, sending more circulating glucose to the liver to be converted into hepatic fat. Breaking this cycle requires intervening in lifestyle, nutrition, and metabolic health. You can explore structured strategies in our overview of metabolic health and body composition.

Alcohol Intake Patterns and Endocrine Disruption

Alcohol intake represents a direct physiological variable that affects both liver pathology and testosterone synthesis. When evaluating midlife hormone health, clinicians must look closely at exact alcohol consumption patterns rather than relying on general descriptions. Clinical guidelines classify liver disease that combines metabolic risk factors with moderate alcohol consumption as MetALD, recognizing that alcohol and metabolic stress compound one another.

The American Association for the Study of Liver Diseases categorizes male alcohol consumption across specific tiers:

• Mild Intake: Up to 30 grams of pure alcohol per day, roughly equivalent to two standard drinks.
• Moderate Intake: Between 31 and 59 grams of pure alcohol per day.
• Heavy Intake: 60 grams or more of pure alcohol per day, representing four or more standard drinks daily.

Alcohol exerts complex, dose-dependent effects on male endocrinology. Acute, low-dose alcohol intake can cause transient, short-term spikes in circulating testosterone due to altered hepatic steroid clearance. However, sustained moderate-to-heavy alcohol consumption directly impairs hormone health through three distinct biological pathways.

First, ethanol and its primary metabolite, acetaldehyde, exert direct toxic effects on testicular Leydig cells, impairing the enzymatic machinery required to convert cholesterol into testosterone. Second, chronic alcohol metabolism in the liver alters the intracellular redox state, depleting cofactors necessary for healthy steroidogenesis and protein production. Third, regular heavy drinking activates the hypothalamic-pituitary-adrenal axis, elevating circulating cortisol. Elevated cortisol acts centrally to suppress pituitary gonadotropin release, driving down testosterone production while accelerating visceral fat storage and liver steatosis.

A single blood test taken after a weekend of heavy social drinking or poor sleep does not reflect a man's true endocrine baseline. Accurate hormone evaluation requires establishing consistent lifestyle conditions and assessing alcohol exposure accurately.

Real-World Impact on Physical Energy, Strength, and Body Composition

The combined effects of liver steatosis, insulin resistance, and altered sex steroids manifest in noticeable daily physical limitations. These changes do not happen overnight. They accumulate gradually through midlife, affecting physical capability, mental clarity, and athletic performance.

Training Performance and Muscle Preservation

When insulin resistance and low bioavailable testosterone coexist, skeletal muscle enters an unfavorable metabolic state. Muscle cells become less efficient at absorbing amino acids and storing glycogen. During resistance training or cardiovascular exercise, you may notice premature fatigue, reduced strength output, and persistent muscle soreness that lingers for days.

Preserving lean mass becomes harder because the body's natural anabolic drive is muted, while systemic inflammatory cytokines promote muscle catabolism. Maintaining regular resistance training remains one of the most effective tools to restore insulin sensitivity. Read our detailed guides on maintaining strength and muscle mass for actionable exercise protocols.

Daily Energy and Mental Sharpness

The liver plays a central role in regulating blood glucose between meals. When fatty liver disease and insulin resistance progress, the liver struggles to maintain steady glucose output, leading to noticeable energy crashes, brain fog, and intense cravings for refined carbohydrates in the afternoon.

Furthermore, subclinical inflammation originating in steatotic liver tissue crosses the blood-brain barrier, contributing to low motivation, mild mood changes, and subjective cognitive sluggishness. Men often attribute these symptoms exclusively to low testosterone, overlooking the underlying metabolic and hepatic instability driving the problem.

Visceral Fat Distribution and Fluid Balance

As androgen-to-estrogen balance shifts and liver function becomes sluggish, body composition shifts toward central fat storage. Even men who maintain a relatively normal body weight on the scale may develop a firm, protruding abdomen. This specific visceral fat profile correlates strongly with increased portal vein pressure, elevated systemic blood pressure, and subtle fluid retention.

Diagnostic Evaluation and Laboratory Testing Strategies

If you suspect your hormone levels or metabolic health are compromised, obtaining a comprehensive, structured laboratory evaluation is critical. A single, random blood draw ordered without specific preparation is clinically unhelpful. The Endocrine Society and leading hepatology guidelines recommend an integrated testing sequence.

Step 1: Accurate Hormone Assessment

To accurately assess androgen status, follow a strict clinical protocol:

• Morning Fasting Tests: Blood draws must occur between 7:00 AM and 10:00 AM after an overnight fast. Testosterone follows a strong circadian rhythm in men, peaking in the early morning hours and dropping significantly by afternoon.
• Repeat Confirmation: A low total testosterone reading must always be confirmed with a second morning fasting test drawn on a separate day. Up to 30 percent of men with an initial low reading show normal levels on repeat testing.
• Fractionation and SHBG: Always order total testosterone, sex hormone-binding globulin, and calculated free testosterone together.
• Central Gonadotropins: Testing luteinizing hormone and follicle-stimulating hormone clarifies whether low testosterone originates from testicular failure (primary) or hypothalamic-pituitary suppression (secondary).

Step 2: Comprehensive Metabolic Panel

Evaluating the metabolic environment requires assessing glucose regulation and cardiovascular lipid fractions:

• Fasting Blood Glucose and HbA1c: Evaluates baseline blood sugar control and average glycation over the preceding three months.
• Fasting Lipid Panel: Assesses total cholesterol, LDL, HDL, and triglycerides. A high triglyceride-to-HDL ratio serves as a reliable surrogate marker for systemic insulin resistance.
• Blood Pressure and Waist Circumference: Simple physical measurements that provide immediate diagnostic context for metabolic syndrome.

Step 3: Liver Enzymes and Hepatic Biomarkers

Evaluating liver health involves looking at hepatocellular injury markers and functional proteins:

• Alanine Aminotransferase and Aspartate Aminotransferase: Enzymes that leak into circulation when liver cells experience acute or chronic stress.
• Platelet Count: A routine complete blood count marker that often drops as liver stiffness and portal hypertension develop.
• Albumin and Bilirubin: Functional markers reflecting the liver's synthetic capability and biliary clearance.

Step 4: Noninvasive Fibrosis Scoring

Standard liver enzyme tests alone cannot confirm or rule out liver fibrosis. Alanine aminotransferase levels can appear completely normal even in patients with significant liver scarring. Clinicians use validated, noninvasive scoring algorithms based on routine blood tests:

• FIB-4 Index: Calculates an estimated fibrosis score using your age, AST, ALT, and platelet count. A low FIB-4 score reliably rules out advanced liver fibrosis, while a high score indicates the need for formal imaging.
• APRI Score: Uses the AST-to-platelet ratio index as an additional noninvasive assessment of hepatic structural changes.
• Hepatic Ultrasound and Transient Elastography: Specialized ultrasound imaging that measures liver fat content and physical tissue stiffness without requiring an invasive liver biopsy.

Illustrative Clinical Evaluation Models

To understand how these laboratory parameters interact in clinical practice, consider these three representative physiological models.

Model A: Metabolic Suppression with Low SHBG

Consider an illustrative model of a 50-year-old man presenting with persistent fatigue, a 41-inch waist circumference, and prediabetes. His initial morning blood panel reveals a total testosterone level well below standard laboratory reference ranges.

However, his SHBG is markedly suppressed, and his calculated free testosterone falls within the normal physiological range. His ALT is mildly elevated, and his FIB-4 score indicates a low risk for advanced fibrosis.

In this scenario, prescribing hormone replacement therapy misinterprets the root problem. The primary clinical priority is addressing visceral adiposity and insulin resistance through dietary changes, resistance exercise, and sleep optimization. As insulin levels drop, hepatic SHBG synthesis normalizes, and total testosterone levels rise naturally without pharmaceutical intervention.

Model B: Cirrhosis with Artificially Preserved Total Testosterone

Consider an illustrative model of a 62-year-old man with a history of long-term heavy alcohol intake and established hepatic cirrhosis. He reports loss of muscle mass, severe lethargy, and low libido. His laboratory testing reveals a total testosterone level sitting comfortably in the middle of the normal reference range.

However, because his damaged liver produces high concentrations of SHBG, his calculated free testosterone is profoundly suppressed. His platelet count is low, and his AST is higher than his ALT.

Focusing solely on his total testosterone number would lead a clinician to believe his hormone levels are adequate. In reality, he suffers from severe functional androgen deficiency driven by liver disease. Management requires close coordination between hepatology and endocrinology specialists, with care focused primarily on stabilizing hepatic function.

Model C: Weekend Alcohol Exposure with Transient Hormone Fluctuations

Consider an illustrative model of a 46-year-old man who undergoes routine executive blood screening on a Monday morning following a high-stress week and heavy weekend alcohol consumption. His blood work shows depressed total testosterone, elevated cortisol, and mildly elevated liver transaminases.

Repeating the identical laboratory panel three weeks later following complete alcohol abstinence, regular sleep, and balanced nutrition reveals completely normalized testosterone and liver enzyme values.

This model illustrates why isolated laboratory snapshots must never be used to initiate lifelong medical therapies. The endocrine system is dynamic, responding rapidly to acute lifestyle stressors, sleep deprivation, and toxic exposures.

Practical Factors for Supporting Metabolic and Liver Health

Clinical research confirms that improving liver function and restoring insulin sensitivity directly supports healthy endogenous hormone production. Evidence points toward several non-prescriptive, foundational lifestyle factors that improve midlife metabolic health.

Nutritional Architecture and Hepatic De-Fatting

Nutrition plays the most direct role in reducing hepatic steatosis and improving insulin signaling. Evidence supports these fundamental nutritional principles:

• Eliminate Added Sugars and Liquid Fructose: Fructose is metabolized almost exclusively by the liver. High-fructose corn syrup and sugary beverages rapidly drive hepatic de novo lipogenesis, accelerating liver fat accumulation.
• Prioritize Whole Protein Sources: Adequate dietary protein provides essential amino acids needed for liver detoxification pathways and muscle protein synthesis. Aim for unprocessed poultry, lean meats, fish, eggs, and quality plant proteins.
• Incorporate Mediterranean Dietary Patterns: Diets rich in monounsaturated fats from extra virgin olive oil, wild-caught fish, nuts, seeds, and leafy vegetables consistently show reductions in hepatic fat and cardiovascular risk markers.
• Caloric Moderation: Achieving a modest, sustained caloric deficit of 500 to 750 calories daily reliably reduces liver fat by up to 30 percent, even before substantial total body weight is lost.

Structured Physical Training

Physical exercise produces immediate improvements in peripheral insulin sensitivity, independent of weight loss:

• Progressive Resistance Training: Lifting weights two to four times per week stimulates GLUT4 glucose transporters in muscle tissue, creating a large metabolic sink for circulating blood sugar.
• Low-Intensity Zone 2 Aerobic Work: Sustained, conversational-pace cardiovascular exercise, such as brisk walking, cycling, or rowing for 30 to 45 minutes several times weekly, enhances mitochondrial density and accelerates cellular fatty acid oxidation.
• Post-Meal Walking: A brief 10 to 15-minute walk immediately following your largest meals significantly blunts postprandial glucose and insulin spikes, reducing the metabolic burden placed on your liver.

Sleep Architecture and Circadian Health

Hormone synthesis and hepatic metabolic recovery are intimately tied to circadian rhythms:

• Maintain Consistent Sleep Windows: Going to bed and waking up at consistent times reinforces central circadian signaling, optimizing morning testosterone release.
• Screen for Obstructive Sleep Apnea: Midlife men with visceral obesity and neck circumferences over 17 inches have a high risk of sleep apnea. Chronic nighttime hypoxia elevates liver enzymes, drives systemic insulin resistance, and severely blunts daytime testosterone production.

For deeper insights into sustainable vitality, explore our broad collection of evidence-based health guidance for men.

Clinical Misconceptions and Flawed Assumptions

Widespread misinformation regarding male hormones and liver health prevents many men from receiving appropriate clinical care. The medical literature directly refutes several common assumptions.

Misconception 1: A Single Low Blood Test Confirms Hypogonadism

Many men receive a testosterone prescription after a single afternoon blood draw ordered during a period of acute fatigue or stress. Clinical practice guidelines firmly state that hypogonadism cannot be diagnosed without at least two separate, confirmed morning fasting lab tests demonstrating low testosterone in the presence of specific physical signs and symptoms.

Misconception 2: Testosterone Replacement Therapy Cures Fatty Liver Disease

Because low testosterone is associated with fatty liver disease, commercial clinics sometimes promote testosterone therapy as a direct cure for liver steatosis, diabetes, or obesity. Current clinical evidence reviews classify the metabolic benefits of testosterone therapy in functional hypogonadism as low certainty. Testosterone replacement is not an approved medical treatment for diabetes, dyslipidemia, or steatotic liver disease, and it cannot replace weight management and dietary changes.

Misconception 3: Normal Liver Enzymes Guarantee a Healthy Liver

Many men assume that an ALT and AST within the standard reference range means their liver is completely healthy. Clinical research demonstrates that simple steatosis, non-alcoholic steatohepatitis, and even advanced bridging fibrosis can exist with completely normal transaminase levels. Calculating a FIB-4 score or obtaining specialized imaging is necessary when metabolic risk factors are present.

Misconception 4: Age Alone Justifies Hormone Prescriptions

Aging is a natural physiological process, not an endocrine disease. The Endocrine Society explicitly recommends against routinely prescribing testosterone therapy to all older men simply because their hormone concentrations are lower than those of a 25-year-old. Treatment decisions must always weigh individual cardiovascular, hematological, and prostate risks against documented clinical benefits.

Misconception 5: Over-the-Counter Testosterone Boosters Are Safe and Effective

Men seeking natural alternatives frequently turn to herbal supplements marketed as hormone boosters. Peer-reviewed analytical studies show that most over-the-counter vitality supplements lack high-quality clinical evidence for raising bioavailable testosterone. Furthermore, unverified dietary supplements represent a leading cause of drug-induced liver injury, introducing unnecessary hepatic strain.

Research Limitations and Gaps in Current Science

While the connections between liver health, insulin sensitivity, and sex steroids are well documented, several areas of clinical science remain incomplete. Understanding these limitations prevents overinterpreting current medical data.

Observational Nature of Large Cohort Studies

Most data linking low testosterone to non-alcoholic fatty liver disease originate from cross-sectional and observational cohort studies. While these studies show clear associations, they cannot prove direct causality. Confounding variables such as visceral fat, diet quality, physical activity, alcohol exposure, and socioeconomic factors make it difficult to determine whether low hormones drive liver disease or liver disease drives low hormones.

Limited Long-Term Interventional Trials on Hepatic Fibrosis

Interventional trials examining the impact of hormone replacement on liver architecture remain limited in scale and duration. While some small studies show modest reductions in liver triglyceride content following testosterone administration in hypogonadal men, large-scale, randomized controlled trials demonstrating the reversal of histologically proven liver fibrosis or cirrhosis complications are lacking.

Variability Across Laboratory Assays

Significant variability exists among commercial laboratory testing platforms, particularly when measuring low-range testosterone and calculated free fractions. Liquid chromatography-tandem mass spectrometry provides the gold standard for hormone measurement, but many standard clinics continue to utilize less accurate direct immunoassay platforms that can produce conflicting results.

For more measured discussions on longevity science and evidence grading, read our resources on strategies for healthy aging.

Summary and Key Considerations

In midlife men, testosterone levels, visceral fat, insulin resistance, and liver health form a single connected physiological network. A low total testosterone reading is often a functional biomarker of metabolic and liver stress rather than an irreversible failure of the testes.

Before considering medical hormone therapy, men over 45 should work with qualified healthcare professionals to confirm hormone levels with repeat morning fasting tests, measure SHBG and free testosterone, thoroughly evaluate liver enzymes and fibrosis risk scores, and aggressively address reversible metabolic and lifestyle factors.

Implementation Checklist for This Week

Use this structured checklist to guide your discussions with your doctor and take control of your metabolic and hormone health:

• Schedule a Structured Morning Lab Panel: Request repeat morning fasting blood tests between 7:00 AM and 10:00 AM, including total testosterone, SHBG, calculated free testosterone, LH, FSH, fasting glucose, HbA1c, fasting lipids, ALT, AST, and a complete blood count.
• Calculate Your Fibrosis Risk: Ask your clinician to calculate your baseline FIB-4 index using your age, AST, ALT, and platelet count to evaluate liver tissue health noninvasively.
• Accurately Track Alcohol Consumption: Record every standard alcoholic drink consumed over a full 14-day period to determine whether your exposure falls into mild, moderate, or heavy clinical tiers.
• Audit Added Sugar and Liquid Calories: Remove all high-fructose corn syrup, fruit juices, sodas, and sweetened coffee drinks from your daily diet to immediately reduce hepatic fat synthesis.
• Implement Baseline Resistance Training: Commit to three 45-minute structured resistance training sessions per week focusing on compound movements to improve muscle insulin sensitivity.
• Add Daily Post-Meal Movement: Incorporate a brisk 10 to 15-minute walk immediately following your largest meal of the day to reduce postprandial glucose and insulin excursions.
• Evaluate Sleep Quality: If you experience chronic snoring, daytime fatigue, or frequent nighttime awakenings, request a formal clinical screening for obstructive sleep apnea.

Sources

1. The Role of SHBG as a Marker in Male Patients with Metabolic ...
2. Sex Hormones and Metabolic Dysfunction-Associated ... - PMC
3. Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. The Copenhagen Study Group for Liver Diseases - PubMed
4. Alcohol's Effects on Male Reproduction - PMC - NIH
5. Associations of Sex Steroids and Sex Hormone-Binding ...
6. The effects of alcohol on testosterone synthesis in men